| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/12/2008 | WO2008108242A1 Brain-migrating polypeptide having polyvalent bond and improved metabolic stability |
| 09/12/2008 | WO2008108209A1 Percutaneously absorbable preparation, process for production thereof and method for percutaneous absorption |
| 09/12/2008 | WO2008107908A1 Compositions comprising peg- interferon alpha conjugates and raffinose as cryoprotectant |
| 09/12/2008 | WO2008107729A1 Sustained release bionanocomposites, a process for producing the same and use thereof |
| 09/12/2008 | WO2008107569A2 Cysteine inclusion complexes and compositions containing same |
| 09/12/2008 | WO2008107471A2 Modified hydroxypolymer conjugates with killing effect on tumor cells |
| 09/12/2008 | WO2008107390A1 Pharmaceutical compositions comprising a calcilytic agent |
| 09/12/2008 | WO2008107260A1 Coupling of antibody polypeptides at the c-terminus |
| 09/12/2008 | WO2008107193A1 Topical composition comprising retinoid receptor agonist for treatment of acne |
| 09/12/2008 | WO2008106787A1 Soft gelatin capsule shells containing oil soluble flavoring and methods of making the same |
| 09/12/2008 | WO2008106702A1 Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue |
| 09/12/2008 | WO2008051363A3 Stable polypeptide formulations |
| 09/12/2008 | WO2008050188A3 Sustained release pharmaceutical compositions of alfuzosin and process for preparation thereof |
| 09/12/2008 | CA2679960A1 Modified hydroxypolymer conjugates with killing effect on tumor cells |
| 09/12/2008 | CA2679765A1 T4 bacteriophage bound to a substrate |
| 09/12/2008 | CA2679743A1 Methods and compositions involving polymeric immunoglobulin fusion proteins |
| 09/12/2008 | CA2679316A1 Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same |
| 09/12/2008 | CA2678794A1 Pharmaceutical compositions comprising a calcilytic agent |
| 09/12/2008 | CA2678538A1 Polyrotaxanes and material having polyrotaxane, crosslinked polyrotaxanes and material having the crosslinked polyrotaxane, and processes for producing these |
| 09/12/2008 | CA2678424A1 Percutaneous administration device of bisoprolol |
| 09/12/2008 | CA2677036A1 Soft gelatin capsule shells containing oil soluble flavoring and methods of making the same |
| 09/11/2008 | US20080221144 Controlled Release Formulations |
| 09/11/2008 | US20080221121 Controlled release of sterile freeze dried aripirazole in water for intramuscular injection |
| 09/11/2008 | US20080221065 Pharmaceutical formulations; epothilone and mannitol or a cyclodextrin parenteral administration in the form of an infusion concentrate or lyophilised composition |
| 09/11/2008 | US20080221062 Non-steroidal anti-inflammatory drugs bound to hyaluronic acid through a covalent bond via a spacer having a biodegradable region and disease-modifying anti-rheumatic drugs; salicylic acid, aspirin, mefenamic acid, tolfenamic acid; arthritis, suppress inflammation and pain; parenteral, topical |
| 09/11/2008 | US20080221051 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 09/11/2008 | US20080221047 Aminoakyl methacrylate copolymer E for maintaining solubility of poorly-soluble drug |
| 09/11/2008 | US20080221020 Dendrimers as Molecular Translocators |
| 09/11/2008 | US20080221017 Pharmaceutical or cosmetic composition and use of a PKC inhibitor with an MMP inhibitor for inhibiting langerhans cell migration |
| 09/11/2008 | US20080220527 Modular transfection systems |
| 09/11/2008 | US20080220095 Red blood cells loaded with s-nitrosothiol and uses therefor |
| 09/11/2008 | US20080220093 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 09/11/2008 | US20080220077 injectable compositions comprising biocompatible, swellable, substantially hydrophilic, non-toxic and substantially spherical polymeric material carriers which are capable of efficiently delivering bioactive therapeutic factor(s) for use in embolization drug therapy |
| 09/11/2008 | US20080220073 The Treatment of Respiratory Diseases |
| 09/11/2008 | US20080220072 Biologic modulations with nanoparticles |
| 09/11/2008 | US20080220061 controlled release dosage forms and methods of designing and manufacturing dosage forms to obtain specific release profiles zero-order release profiles, escalating release profiles or decreasing release profiles. The dosage forms of the present invention can include spatial variation of API dosage forms |
| 09/11/2008 | US20080220054 Modulation of drug release rate from electrospun fibers |
| 09/11/2008 | US20080220020 Transdermal Botulinum Toxin Compositions |
| 09/11/2008 | US20080220002 Modified transferin-antibody fusion proteins |
| 09/11/2008 | US20080219999 Immunoadhesin for the prevention of rhinovirus infection |
| 09/11/2008 | US20080219994 Modified bouganin proteins, cytotoxins and methods and uses thereof |
| 09/11/2008 | US20080219980 Bi-Specific Complexes for Targeting Cells Involved in Allergic-Type Reactions, Compositions and Uses Thereof |
| 09/11/2008 | US20080219951 Fluid mixture for enhancing implantable drug delivery at body temperature |
| 09/11/2008 | US20080219924 Imaging, diagnosis and treatment of disease |
| 09/11/2008 | DE102007011485A1 Darreichungsform mit erschwertem Missbrauch Dosage form with impeded abuse |
| 09/10/2008 | EP1967586A1 84P2A9: A prostate and testis specific protein highly expressed in prostate cancer |
| 09/10/2008 | EP1967528A2 CDR-Grafted type III anti-cea humanized mouse monoclonal antibodies |
| 09/10/2008 | EP1967212A2 Four branched dendrimer-peg for conjugation to proteins and peptides |
| 09/10/2008 | EP1967211A1 Method of producing solid preparation disintegrating in the oral cavity |
| 09/10/2008 | EP1967206A2 Anti-IgE vaccines |
| 09/10/2008 | EP1967205A2 Anti-IgE vaccines |
| 09/10/2008 | EP1967188A1 Pharmaceutical preparation of aqueous solution containing platinum complex |
| 09/10/2008 | EP1967185A1 Hydrogel-driven drug dosage form |
| 09/10/2008 | EP1967184A1 Controlled release solid preparation |
| 09/10/2008 | EP1967183A1 Controlled release solid preparation |
| 09/10/2008 | EP1967180A1 Topical composition comprising a retinoid receptor agonist |
| 09/10/2008 | EP1967067A2 Use of neuronal sodium channel antagonists together with amitraz for the control of ectoparasites in homeothermic animals |
| 09/10/2008 | EP1966388A2 Targeting vector-phospholipid conjugates |
| 09/10/2008 | EP1965816A2 Pharmaceutical compositions and methods for treating or preventing oxalate-related disease |
| 09/10/2008 | EP1965787A2 Treatment of xerostomia with a sulfur-containing antioxidant |
| 09/10/2008 | EP1965767A2 Pharmaceutical product comprising porous silicon |
| 09/10/2008 | EP1677811B1 Medicament on the basis of honey, preparation and use thereof |
| 09/10/2008 | EP1578415B1 Dosage forms comprising a cetp inhibitor and an hmg-coa reductase inhibitor |
| 09/10/2008 | EP1551417B1 Three layer tear formulation |
| 09/10/2008 | EP1503741B1 Diffusion-controlled dosage form and method of fabrication including three dimensional printing |
| 09/10/2008 | EP1492531B1 Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin |
| 09/10/2008 | EP1448666B1 Bioerodible poly(ortho esters) containing amine groups, and block copolymers containing them |
| 09/10/2008 | EP1441771B1 Aqueous sustained-release formulations of proteins |
| 09/10/2008 | EP1392375B1 Composition and use of substances for stabilising amino acids containing sulphur |
| 09/10/2008 | EP1289570B1 Liposomal encapsulation of alpha-emitters and uses thereof |
| 09/10/2008 | EP1261337B1 Topoisomerase inhibitors for treatment of surgical adhesions |
| 09/10/2008 | EP1163901B1 Chewable soft capsules having improved administration properties and process for producing the same |
| 09/10/2008 | EP1159006B1 Water-soluble compositions of bioactive lipophilic compounds |
| 09/10/2008 | EP1077691B1 Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same |
| 09/10/2008 | EP1067911B1 Hydrogel compositions useful for the sustained release of macromolecules and methods of making same |
| 09/10/2008 | EP1062232B1 Molecules that home to various selected organs or tissues |
| 09/10/2008 | EP0901371B1 Alteration of microbial populations in the gastrointestinal tract |
| 09/10/2008 | EP0873415B1 Fusion protein delivery system and uses thereof |
| 09/10/2008 | CN101263159A Compositions and methods for the diagnosis and treatment of tumor |
| 09/10/2008 | CN101262890A Use of aprotinin polypeptides as carriers in pharmaceutical conjugates |
| 09/10/2008 | CN101262889A Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine |
| 09/10/2008 | CN101262888A Formulations for enhanced mucosal delivery of PYY |
| 09/10/2008 | CN101262887A Prevention and treatment of ophthalmic complications of diabetes |
| 09/10/2008 | CN101262886A Formulation and method for administration of ophthalmologically active agents |
| 09/10/2008 | CN101262885A Pharmaceutical compositions containing sc(Fv)2 |
| 09/10/2008 | CN101262862A Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof |
| 09/10/2008 | CN101262858A Adhesive medicament preparation containing bisoprolol |
| 09/10/2008 | CN101262857A 3-(2-dimethylaminomethyl cyclohexyl) phenol retard formulation |
| 09/10/2008 | CN101262848A Antifungal composition |
| 09/10/2008 | CN101260419A Alpha-isomaltosylglucosaccharide forming enzyme, preparation method and uses of the same |
| 09/10/2008 | CN101260191A Temperature sensitive type chitosan/glutin hydrogel and its preparation method and use |
| 09/10/2008 | CN101259289A Methods and compositions for therapeutic use of RNA interference |
| 09/10/2008 | CN101259287A Application of LDP protein as tumor target medicine guiding carrier |
| 09/10/2008 | CN101259286A Method for constructing liver target drug-carrying polymer micelle |
| 09/10/2008 | CN101259285A Application of 2-chitosan salicylic acid graft compound in anticoagulant and long-acting ease pain |
| 09/10/2008 | CN101259284A Liver target anticancer nano prodrug system based on tree shaped polymer, preparation and use |
| 09/10/2008 | CN101259283A Anti-depression noncovalent complex with high dissolvability and preparation thereof |
| 09/10/2008 | CN101259282A Tumor targeting macromolecule controlled-release anti-cancer medicine and synthesizing method and use |
| 09/10/2008 | CN101259281A Tumor targeting poly-asparagine free radical compounds and synthesizing method and use |
| 09/10/2008 | CN101259280A Biodegradable ocular implant |